Supplementary Material for: Reinfusion of malignant ascites through an extracorporeal peritoneal-venous shunt to avoid complications and assess the safety of a Denver shunt: A Case Report

静脉医学研究

Background: Malignant ascites due to peritoneal metastasis of gastric cancer is challenging to manage, especially in frail and elderly patients. Traditional treatments like diuretics and paracentesis

DataCite Commons2025-01-31 更新70

Additional file 1 of Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience

恶性腹水治疗

临床不良反应评估

Additional file 1: Table S1. The evaluation of parameters associated with AEs in CART therapy excluding two cases who received CART more than 10 times.

Figshare2022-03-15 更新20

DataSheet1_A novel form of docetaxel polymeric micelles demonstrates anti-tumor and ascites-inhibitory activities in animal models as monotherapy or in combination with anti-angiogenic agents.docx

肿瘤药物输送

恶性腹水治疗

Malignant ascites (MA) is caused by intraperitoneal spread of solid tumor cells and results in a poor quality of life. Chemotherapy is a common first-line treatment for patients with MA. Taxotere ® (D

NIAID Data Ecosystem10

Additional file 1 of Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience

资源简介：

相关数据集